| Family: | Invesco |
| Name: | Invesco NASDAQ Future Gen 200 ETF |
| Inception Date: | 13-Oct-2022 |
| Termination Date: | |
| Investment Objective: | The Invesco NASDAQ Future Gen 200 ETF (Fund) is based on the Nasdaq Innovators Completion Cap Index (Index). The Fund will invest at least 90% of its total assets in the securities that comprise the Index. The Index consists of 200 small cap companies with the most valuable patent portfolios relative to their total market value as deemed by Nasdaq. The eligible universe consists of the companies within the Nasdaq Composite Index, excluding those companies included in the Nasdaq-100 Index and Nasdaq Next Generation 100 Index. Each constituent within the Index is equally weighted. The Fund and Index are rebalanced quarterly and reconstituted semi-annually. |
| Prospectus | |
| Top 10 Holdings | ||
| Newell Brands Inc | NWL | 0.8500% |
| Myriad Genetics Inc | MYGN | 0.7500% |
| ClearPoint Neuro Inc | CLPT | 0.7300% |
| Arqit Quantum Inc | ARQQ | 0.7100% |
| QuidelOrtho Corp | QDEL | 0.7000% |
| Cartesian Therapeutics Inc | RNAC | 0.7000% |
| Quanterix Corp | QTRX | 0.7000% |
| 10X Genomics Inc | TXG | 0.6900% |
| Cybin Inc | HELP | 0.6800% |
| Ligand Pharmaceuticals Inc | LGND | 0.6800% |
| Top 10 Holdings Weight: | 7.2% |
| Number of Holdings: | 205 |
| Shares Outstanding: | 500,001 |
| Total Net Assets: | 22,253,290 |
| NAV: | 44.46 |
| Net Expense Ratio: | 0.20% |
| Asset Class: | Equities (Stocks) |
| Developed or Emerging: | Developed Market Funds |
| Country: | US |
| Region: | |
| Strategy: | |
| Currency: | |
| Commodity: | |
| Sector: | |
| Industry: | |
| Dividend Type: | |
| Tax Exempt State: | |
| Maturity Duration: | |
| Market Cap: | Small Cap |
| Credit Quality: | |
| Mortgage Bond Types: | |
| Bond Type: | |
| Gov't Bond Types: | |
| Reit Type: | |
| Leverage Direction/Factor: | |
| Is Currency Hedged: | No |
| US or Ex-US: | Domestic |
